Abrdn Life Sciences Investors (HQL) Competitors $12.72 -0.11 (-0.82%) Closing price 05/1/2025 03:58 PM EasternExtended Trading$12.70 -0.03 (-0.24%) As of 05/1/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HQL vs. GSBD, CET, MFIC, NMFC, MUC, BCSF, BBDC, AWF, PFLT, and HQHShould you be buying Abrdn Life Sciences Investors stock or one of its competitors? The main competitors of Abrdn Life Sciences Investors include Goldman Sachs BDC (GSBD), Central Securities (CET), MidCap Financial Investment (MFIC), New Mountain Finance (NMFC), BlackRock MuniHoldings California Quality Fund (MUC), Bain Capital Specialty Finance (BCSF), Barings BDC (BBDC), AllianceBernstein Global High Income Fund (AWF), PennantPark Floating Rate Capital (PFLT), and Abrdn Healthcare Investors (HQH). These companies are all part of the "financial services" industry. Abrdn Life Sciences Investors vs. Goldman Sachs BDC Central Securities MidCap Financial Investment New Mountain Finance BlackRock MuniHoldings California Quality Fund Bain Capital Specialty Finance Barings BDC AllianceBernstein Global High Income Fund PennantPark Floating Rate Capital Abrdn Healthcare Investors Abrdn Life Sciences Investors (NYSE:HQL) and Goldman Sachs BDC (NYSE:GSBD) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation, community ranking and profitability. Is HQL or GSBD more profitable? Goldman Sachs BDC has a net margin of 17.01% compared to Abrdn Life Sciences Investors' net margin of 0.00%. Goldman Sachs BDC's return on equity of 15.72% beat Abrdn Life Sciences Investors' return on equity.Company Net Margins Return on Equity Return on Assets Abrdn Life Sciences InvestorsN/A N/A N/A Goldman Sachs BDC 17.01%15.72%7.08% Which has more volatility & risk, HQL or GSBD? Abrdn Life Sciences Investors has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Goldman Sachs BDC has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Does the media favor HQL or GSBD? In the previous week, Goldman Sachs BDC had 5 more articles in the media than Abrdn Life Sciences Investors. MarketBeat recorded 9 mentions for Goldman Sachs BDC and 4 mentions for Abrdn Life Sciences Investors. Goldman Sachs BDC's average media sentiment score of 0.92 beat Abrdn Life Sciences Investors' score of 0.83 indicating that Goldman Sachs BDC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abrdn Life Sciences Investors 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Goldman Sachs BDC 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in HQL or GSBD? 32.2% of Abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 28.7% of Goldman Sachs BDC shares are held by institutional investors. 10.1% of Abrdn Life Sciences Investors shares are held by company insiders. Comparatively, 0.1% of Goldman Sachs BDC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community believe in HQL or GSBD? Goldman Sachs BDC received 179 more outperform votes than Abrdn Life Sciences Investors when rated by MarketBeat users. However, 68.35% of users gave Abrdn Life Sciences Investors an outperform vote while only 55.24% of users gave Goldman Sachs BDC an outperform vote. CompanyUnderperformOutperformAbrdn Life Sciences InvestorsOutperform Votes9568.35% Underperform Votes4431.65% Goldman Sachs BDCOutperform Votes27455.24% Underperform Votes22244.76% Which has stronger earnings & valuation, HQL or GSBD? Goldman Sachs BDC has lower revenue, but higher earnings than Abrdn Life Sciences Investors. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbrdn Life Sciences Investors$86.69M4.24N/AN/AN/AGoldman Sachs BDC$78.71M15.56$195.87M$0.5718.32 Do analysts prefer HQL or GSBD? Goldman Sachs BDC has a consensus price target of $12.00, suggesting a potential upside of 14.94%. Given Goldman Sachs BDC's stronger consensus rating and higher possible upside, analysts plainly believe Goldman Sachs BDC is more favorable than Abrdn Life Sciences Investors.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abrdn Life Sciences Investors 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Goldman Sachs BDC 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Is HQL or GSBD a better dividend stock? Abrdn Life Sciences Investors pays an annual dividend of $1.47 per share and has a dividend yield of 11.6%. Goldman Sachs BDC pays an annual dividend of $1.28 per share and has a dividend yield of 12.3%. Goldman Sachs BDC pays out 224.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. SummaryGoldman Sachs BDC beats Abrdn Life Sciences Investors on 11 of the 16 factors compared between the two stocks. Get Abrdn Life Sciences Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HQL vs. The Competition Export to ExcelMetricAbrdn Life Sciences InvestorsInvestment offices IndustryFinance SectorNYSE ExchangeMarket Cap$367.40M$6.70B$11.11B$18.96BDividend Yield15.54%6.92%5.77%4.01%P/E RatioN/A3.5222.1032.87Price / Sales4.2421.5626.3128.03Price / CashN/A7.5117.6017.52Price / BookN/A0.862.674.47Net IncomeN/A$66.51M$1.03B$1.02B7 Day Performance1.80%0.88%0.72%0.59%1 Month Performance3.37%-2.09%-0.57%-3.54%1 Year Performance-5.60%1.62%537.59%3.80% Abrdn Life Sciences Investors Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HQLAbrdn Life Sciences InvestorsN/A$12.73-0.8%N/A-4.3%$367.40M$86.69M0.00N/AShort Interest ↑GSBDGoldman Sachs BDC2.0669 of 5 stars$10.37-2.1%$13.00+25.4%-33.2%$1.22B$78.71M14.81N/AUpcoming EarningsAnalyst ForecastCETCentral SecuritiesN/A$41.62-2.0%N/A+9.1%$1.20B$296.20M0.006News CoveragePositive NewsMFICMidCap Financial Investment2.7552 of 5 stars$11.48-2.4%$14.50+26.3%-23.2%$1.08B$110.35M7.36N/AAnalyst ForecastNews CoverageNMFCNew Mountain Finance2.0204 of 5 stars$9.56-1.8%$11.00+15.1%-22.8%$1.03B$123.78M9.10N/AUpcoming EarningsAnalyst ForecastShort Interest ↑News CoverageMUCBlackRock MuniHoldings California Quality FundN/A$10.15-1.3%N/A-0.8%$974.84M$6.39M0.00147,000BCSFBain Capital Specialty Finance2.4256 of 5 stars$14.46-3.3%$18.00+24.5%-11.1%$934.33M$138.19M7.271,000Upcoming EarningsAnalyst ForecastShort Interest ↑News CoverageBBDCBarings BDC1.3682 of 5 stars$8.50-2.3%$9.50+11.8%-9.4%$895.98M$123.59M8.1726Upcoming EarningsAnalyst ForecastAWFAllianceBernstein Global High Income FundN/A$10.05-0.8%N/A+1.3%$866.61M$152.17M0.00N/AShort Interest ↑PFLTPennantPark Floating Rate Capital2.5401 of 5 stars$9.43-2.9%$11.38+20.6%-12.7%$829.43M$114.06M6.74658Positive NewsHQHAbrdn Healthcare InvestorsN/A$15.13+0.2%N/A-1.8%$814.93M$186.46M0.00147,000Short Interest ↑ Related Companies and Tools Related Companies GSBD Competitors CET Competitors MFIC Competitors NMFC Competitors MUC Competitors BCSF Competitors BBDC Competitors AWF Competitors PFLT Competitors HQH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HQL) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HQL Stock Free HQL Stock Alerts